Stamaril

Stamaril is a live, attenuated yellow fever vaccine derived from the 17D-204 strain, used for active immunization against yellow fever. This vaccine is administered via injection and is recommended for travelers to endemic regions. Store between 2°C and 8°C to maintain potency. Always consult a healthcare provider for personalized advice.

Stamaril is used to protect individuals from yellow fever, a viral infection spread by infected mosquitoes. It is primarily indicated for travelers visiting areas where yellow fever is endemic or for those requiring proof of vaccination for entry. The vaccine stimulates the immune system to produce antibodies against the virus, providing long-term protection. It is not suitable for everyone and should be evaluated by a healthcare professional.

After administration, Stamaril prompts the immune system to recognize and fight the yellow fever virus. Common effects include mild pain, redness, or swelling at the injection site. Some individuals may experience low-grade fever, headache, or muscle aches, which typically resolve within a few days. These are normal responses as the body builds immunity.

Stamaril should be handled with care to maintain its potency; store between 2°C and 8°C and avoid freezing. It is not recommended for individuals with severe allergies to eggs or previous doses of the vaccine. Pregnant or breastfeeding women should consult a healthcare provider before use. Always inform your healthcare provider of any medical conditions or medications you are taking.

Stamaril may interact with immunosuppressive therapies, including corticosteroids or chemotherapy, potentially reducing its effectiveness. Avoid receiving other live vaccines within 4 weeks unless directed by a healthcare provider. Blood or plasma transfusions may also interfere with the vaccine's efficacy. Discuss your full medical history with your healthcare provider before vaccination.